ClinicalMetric / Countries / Japan / pulmonary arterial hypertension
← 🇯🇵 Japan Trials
🇯🇵 Japan Country × Condition

pulmonary arterial hypertension Clinical Trials in Japan

Active clinical trials for pulmonary arterial hypertension with research sites in Japan. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 Phases: Phase 2 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇯🇵 Japan

Active Trials in Japan (1)

NCT07441200 Phase 2
Recruiting

Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)

Enrollment
135 pts
Country
🇯🇵 Japan
NS Pharma, Inc.
View Trial →

Frequently Asked Questions

How many pulmonary arterial hypertension clinical trials are active in Japan?
There are currently 1 active clinical trials for pulmonary arterial hypertension with sites in Japan, of which 1 are actively recruiting patients.
How can I join a pulmonary arterial hypertension clinical trial in Japan?
To join a pulmonary arterial hypertension clinical trial in Japan, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Japan directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are pulmonary arterial hypertension trials in Japan?
Active pulmonary arterial hypertension trials in Japan span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Japan Trials → Global pulmonary arterial hypertension Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology